Key facts
- It has raised $6.3M; the latest was Accelerator/Incubator in Feb 2026.
- Notable investors include Plug and Play Tech Center.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Anivance AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Anivance AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Anivance AI
Manufacturer of a physical AI infrastructure platform intended to generate decision-grade human biology for research and development. The company offers integrated organ-on-chip and microphysiological systems, standardized and automated biological execution, and AI-driven data and analysis pipelines, enabling pharmaceutical and biotechnology teams to produce comparable biological signals across organs and conditions and translate them into actionable research decisions.
- Sector
- Healthcare
- HQ
- Zhubei, Taiwan
- Founded
- 2024
- Employees
- 40
- Website
- anivance.io/
- Ownership
- Privately Held (backing)
Anivance AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Anivance AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Anivance AI in its N-PORT filings yet. We sweep new filings monthly.